PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01997112

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01997112
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01997112. Randomized; quadruple masking; primary purpose supportive care. Start 2014-01 (registry gives no type); primary completion 2019-06-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
Acronym
PATH-BP
Condition
Blood Pressure
Intervention (Drug)
Paracetamol
Intervention (Drug)
Placebo oral capsule
Lead sponsor
University of Edinburgh (class: other)
Collaborator
British Heart Foundation (class: other)
Collaborator
National Health Service, United Kingdom (class: other government)

Record details

Record id
cardio:ct-nct01997112
Content hash
84d0f67b90e3c1be1aba2d895dd33f63e9b059639c5e8d8c24d40ef827fc14f5